-
TARS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Tarsus Pharmaceuticals (TARS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 176.21 mm | 176.21 mm | 176.21 mm | 176.21 mm | 176.21 mm | 176.21 mm |
Cash burn (monthly) | 1.63 mm | 4.21 mm | 8.39 mm | 11.72 mm | 2.88 mm | 8.35 mm |
Cash used (since last report) | 6.55 mm | 16.91 mm | 33.74 mm | 47.13 mm | 11.60 mm | 33.58 mm |
Cash remaining | 169.66 mm | 159.30 mm | 142.47 mm | 129.08 mm | 164.61 mm | 142.63 mm |
Runway (months of cash) | 104.2 | 37.9 | 17.0 | 11.0 | 57.1 | 17.1 |
13F holders | Current |
---|---|
Total holders | 169 |
Opened positions | 38 |
Closed positions | 26 |
Increased positions | 58 |
Reduced positions | 42 |
13F shares | Current |
---|---|
Total value | 1.36 tn |
Total shares | 53.75 mm |
Total puts | 4.10 k |
Total calls | 483.70 k |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 3.76 mm | $123.52 bn |
RTW Investments | 3.41 mm | $112.24 bn |
Paradigm Biocapital Advisors | 2.44 mm | $80.27 bn |
Tang Capital Management | 2.25 mm | $74.16 bn |
MS Morgan Stanley | 2.21 mm | $72.64 bn |
Cowen And | 2.20 mm | $72.27 bn |
Jennison Associates | 2.18 mm | $71.65 bn |
Vanguard | 2.10 mm | $68.98 bn |
Tang Capital Partners | 2.00 mm | $0.00 |
Limited Partnership VIII Horowitz | 1.99 mm | $42.15 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Nov 24 | Katherine Goodrich | RSU Common Stock | Grant | Acquire A | No | No | 0 | 6,700 | 0.00 | 6,700 |
13 Nov 24 | Katherine Goodrich | Stock Option Common Stock | Grant | Acquire A | No | No | 46.51 | 10,000 | 465.10 k | 10,000 |
4 Nov 24 | Elizabeth Yeu Lin | RSU Common Stock | Grant | Acquire A | No | No | 0 | 27,278 | 0.00 | 27,278 |
4 Nov 24 | Elizabeth Yeu Lin | Stock Option Common Stock | Grant | Acquire A | No | No | 46.21 | 41,074 | 1.90 mm | 41,074 |
30 Sep 24 | Morrison Scott W | Common Stock | Gift | Dispose G | No | No | 0 | 6,016 | 0.00 | 0 |
15 Sep 24 | Morrison Scott W | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,333 | 0.00 | 6,016 |
15 Sep 24 | Morrison Scott W | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,333 | 0.00 | 1,334 |